Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
JRSM Cardiovascular Disease|March 26, 2026
Sepsis-associated myocarditis: Epidemiology, pathophysiology, diagnosis, management, and future directionsKedir Negesso Tukeni, Mohammed Mecha Abafogi, Kidus Tesfaye Bezabih, et al.
JRSM Cardiovascular Disease|May 28, 2026
Decongestion in chronic heart failureAntohi Laura, Mihaileanu Serban
JRSM Cardiovascular Disease|April 28, 2026
Electrical cardioversion in patients with left ventricular thrombus: A systematic review of safety and thromboembolic riskCarlson Sama, Muchi Ditah Chobufo, Ademola Ajibade, et al.
JRSM Cardiovascular Disease|May 15, 2026
Coronary atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions: A systematic review and meta-analysisOmar Kasimieh, Yashaswi Guntupalli, Prapti Atul Patel, et al.
JRSM Cardiovascular Disease|March 16, 2026
Temporal change of lymphocyte subunits for maladaptive remodeling after anterior myocardial infarctionFerhat Eyyupkoca, Huseyin Oren, Onur Yildirim, et al.
JRSM Cardiovascular Disease|February 27, 2014
Aldosterone synthase inhibitors in hypertension: current status and future possibilitiesMilan Hargovan, Albert Ferro
JRSM Cardiovascular Disease|February 24, 2017
Beneficial effects of nonpharmacological interventions in the management of essential hypertensionAnastasios Vamvakis, Eugenia Gkaliagkousi, Areti Triantafyllou, et al.
JRSM Cardiovascular Disease|February 24, 2017
Effects of renal denervation on vascular remodelling in patients with heart failure and preserved ejection fraction: A randomised control trialHitesh C Patel, Carl Hayward, Jennifer Keegan, et al.
JRSM Cardiovascular Disease|October 11, 2016
Association of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms with obesity and their relationship with body mass index, lipoprotein and hypertension among young age SaudisHamoud A Almoshabek, Md Mustafa, Mohammed M Al-Asmari, et al.
JRSM Cardiovascular Disease|April 15, 2020
Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillationAlexander Birkinshaw, Christopher H Fry, David Fluck, et al.
Pageof 28